19-17

Title: 19-17







Description

Advisory to FCMs and time-limited no-action relief to DCOs with respect to the treatment of separate accounts by FCMs.

19-15

Title: 19-15







Description

No-action relief from specified Part 39 regulations applicable to derivatives clearing organizations due to Eris Clearing, LLC’s fully-collateralized clearing model.

19-09

Title: 19-09







Description

This staff letter ensures that existing regulatory relief provided by DSIO, DMO, and DCR pursuant to certain existing staff letters affecting EU entities continues to be available for UK entities following Brexit.

18-32

Title: 18-32







Description

No-Action Relief to Eurex Clearing AG to allow certain modifications to the acknowledgment letter that Eurex is required to obtain from the Deutsche Bundesbank

18-31

Title: 18-31







Description

Conditional No-Action Relief to Eurex Clearing AG and its FCM Clearing Members to hold customer margin in the form of securities at Clearstream Banking AG

18-30

Title: 18-30







Description

Confirmation that Eurex Clearing AG has demonstrated compliance with the straight-through-processing requirements of Regulation 39.12(b)(7) and approval of certain Eurex rules.

18-18

Title: 18-18







Description

Extension of time-limited no-action relief for Shanghai Clearing House with regard to Section 5b(a) of the Commodity Exchange Act and Commission Regulations thereunder.

18-14

Title: 18-14







Description

Advisory for exchanges and clearinghouses with respect to Virtual Currency Derivative Product Listings.

18-04

Title: 18-04







Description

No-Action Extension of time-limited no-action relief for Shanghai Clearing House with regard to Section 5b(a) of the Commodity Exchange Act and Commission Regulations thereunder.

17-66

Title: 17-66







Description

No-action letter extending the time-limitation contained in an alternative compliance framework available to certain affiliated counterparties pursuant to Commission regulation 50.52(b)(4)(ii)-(iii), extending the time-limitation permitting certain affiliated counterparties located in Australia and Mexico to use the compliance framework under regulation 50.52(b)(4)(ii), and providing analogous relief to certain affiliated counterparties located in Canada, Hong Kong, and Switzerland.